Efficacy of erenumab (AMG 334) in chronic migraine patients with prior prophylactic treatment failure: Subgroup analysis of the phase 2, randomised, double-blind, placebo-controlled study

被引：0

作者：

Ashina, Messoud ^{[1
,2
,3
]}

Tepper, Stewart J. ^{[4
]}

Brandes, Jan Lewis ^{[5
,6
]}

Reuter, Uwe ^{[7
]}

Boudreau, Guy P. ^{[8
]}

Dolezil, David ^{[9
]}

Cheng, Sunfa ^{[10
]}

Leonardi, Dean ^{[10
]}

Lenz, Robert A. ^{[10
]}

Klatt, Jan ^{[11
]}

Mikol, Daniel D. ^{[10
]}

机构：

[1] Rigshosp, Danish Headache Ctr, Glostrup, Denmark

[2] Rigshosp, Dept Neurol, Glostrup, Denmark

[3] Univ Copenhagen, Fac Med & Hlth Sci, Copenhagen, Denmark

[4] Geisel Sch Med Dartmouth, Hanover, NH USA

[5] Nashville Neurosci Grp, Nashville, TN USA

[6] Vanderbilt Univ, Sch Neurol, Nashville, TN 37235 USA

[7] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany

[8] Univ Hosp Ctr Montreal, Neurol Dept, Headache Unit, Montreal, PQ, Canada

[9] DADO Med Sro, Prague Headache Ctr, Prague, Czech Republic

[10] Amgen Inc, Thousand Oaks, CA 91320 USA

[11] Novartis Pharma AG, Basel, Switzerland

来源：

JOURNAL OF HEADACHE AND PAIN | 2017年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页数：1

共 50 条

[21] EFFICACY OF ERENUMAB IN PATIENTS WITH CHRONIC MIGRAINE ACHIEVING ≥50% RESPONSE: SUBGROUP ANALYSIS OF A DOUBLE-BLIND, RANDOMISED STUDY
Dolezil, D.
Klatt, J.
Cheng, S.
Zhang, F.
Wen, S.
RItter, S.
Mikol, D. D.
CEPHALALGIA, 2018, 38 : 92 - 93
[22] Results of a randomized, double-blind, placebo-controlled, phase 2 study to evaluate the efficacy and safety of AMG 334 for the prevention of episodic migraine
Lenz, R.
Silberstein, S.
Dodick, D.
Reuter, U.
Ashina, M.
Saper, J.
Cady, R.
Chon, Y.
Dietrich, J.
Sun, H.
CEPHALALGIA, 2015, 35 : 5 - 5
[23] Efficacy of erenumab in patients with chronic migraine achieving ≥50% response: Subgroup analysis of a double-blind, randomised study
Dolezil, David
Klatt, Jan
Cheng, Sunfa
Zhang, Feng
Wen, Shihua
Ritter, Shannon
Mikol, Daniel D.
JOURNAL OF HEADACHE AND PAIN, 2018, 19
[24] Botulinum toxin A in the prophylactic treatment of migraine - a randomised, double-blind, placebo-controlled study
Schwaag, S
Vollmer-Haase, J
Rahmann, A
Frese, A
Husstedt, IW
Evers, S
CEPHALALGIA, 2003, 23 (07) : 702 - 702
[25] Patient-Reported Outcomes in Chronic Migraine Patients with Prior Prophylactic Treatment Failure Receiving Placebo or Erenumab: Subgroup Analysis of a Pivotal Randomised Study
Lanteri-Minet, M.
Buse, D.
Starling, A. J.
Ailani, J.
Zhang, F.
Wen, S.
Bilitou, A.
Desai, P.
Cheng, S.
Klatt, J.
Mikol, D.
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 409 - 409
[26] PATIENT-REPORTED OUTCOMES IN CHRONIC MIGRAINE PATIENTS WITH PRIOR PROPHYLACTIC TREATMENT FAILURE RECEIVING PLACEBO OR ERENUMAB: SUBGROUP ANALYSIS OF A PIVOTAL RANDOMISED STUDY
Lanteri-Minet, M.
Buse, D. C.
Starling, A.
Ailani, J.
Zhang, F.
Wen, S.
Bilitou, A.
Desai, P.
Cheng, S.
Klatt, J.
Mikol, D. D.
CEPHALALGIA, 2018, 38 : 49 - 50
[27] Botulinum toxin type A (DYSPORT) as a prophylactic treatment of migraine: a double-blind, randomised, placebo-controlled study
Sikaroodi, H
Lotfi, J
Fathi, D
JOURNAL OF NEUROLOGY, 2004, 251 : 144 - 144
[28] A randomised, double-blind, placebo-controlled study of erenumab safety in patients with stable angina
Depre, Christophe
Antalik, Lubomir
Starling, Amaal
Koren, Michael
Eisele, Osaro
Mikol, Daniel D.
JOURNAL OF HEADACHE AND PAIN, 2018, 19
[29] Erenumab treatment for migraine prevention in Japanese patients: Efficacy and safety results from a Phase 3, randomized, double-blind, placebo-controlled study
Takeshima, Takao
Sakai, Fumihiko
Hirata, Koichi
Imai, Noboru
Matsumori, Yasuhiko
Yoshida, Ryuji
Peng, Cheng
Cheng, Sunfa
Mikol, Daniel D.
HEADACHE, 2021, 61 (06): : 927 - 935
[30] A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ERENUMAB IN MIGRAINE PREVENTION: PRIMARY RESULTS OF THE ARISE TRIAL
Dodick, David
Ashina, Messoud
Kudrow, David
Lanteri-Minet, Michel
Osipova, Vera
Palmer, Kerry
Picard, Hernan
Mikol, Daniel D.
Lenz, Robert A.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05):

← 1 2 3 4 5 →